Stay updated on Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the study record itself.
    Difference
    0.0%
    Check dated 2026-04-27T07:34:22.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-20T02:11:06.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page revision changed from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T04:45:03.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T17:32:19.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Updated the study site list with many new locations and institutions, and removed several previously listed sites. The total number of locations is now 264.
    Difference
    3%
    Check dated 2026-02-28T12:39:18.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the Conditions list and a Genetic and Rare Diseases Information Center resource was linked in Resources. The page revision is updated to v3.4.2 from v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-14T05:11:05.000Z thumbnail image

Stay in the know with updates to Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.